Cargando…
Efficacy of a Multi-Strain Probiotic Formulation in Pediatric Populations: A Comprehensive Review of Clinical Studies
A probiotic formulation combining Lactobacillus helveticus Rosell(®)-52, Bifidobacterium infantis Rosell(®)-33, and Bifidobacterium bifidum Rosell(®)-71 with fructooligosaccharides, first commercialized in China, has been sold in over 28 countries since 2002. Clinical studies with this blend of stra...
Autores principales: | Tremblay, Annie, Xu, Xiaoyu, Colee, James, Tompkins, Thomas A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8226750/ https://www.ncbi.nlm.nih.gov/pubmed/34206098 http://dx.doi.org/10.3390/nu13061908 |
Ejemplares similares
-
Discovery of a Novel Multi-Strains Probiotic Formulation with Improved Efficacy toward Intestinal Inflammation
por: Biagioli, Michele, et al.
Publicado: (2020) -
Efficacy of Bifidobacterium longum alone or in multi-strain probiotic formulations during early life and beyond
por: Mills, Susan, et al.
Publicado: (2023) -
Fecal Recovery of Probiotics Administered as a Multi-Strain Formulation during Antibiotic Treatment
por: Forssten, Sofia D., et al.
Publicado: (2020) -
Probiotic Medilac-S(®) for the induction of clinical remission in a Chinese population with ulcerative colitis: A systematic review and meta-analysis
por: Sohail, Ghania, et al.
Publicado: (2018) -
In vitro assessment of probiotic attributes for strains contained in commercial formulations
por: Mazzantini, Diletta, et al.
Publicado: (2022)